Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,806 | 253 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $903.65 | 42 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $608.42 | 37 | $0 (2021) |
| Horizon Therapeutics plc | $511.52 | 32 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $378.60 | 19 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $362.06 | 18 | $0 (2024) |
| Lilly USA, LLC | $237.28 | 13 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $180.07 | 10 | $0 (2021) |
| Amarin Pharma Inc. | $168.21 | 11 | $0 (2021) |
| Novo Nordisk Inc | $164.10 | 8 | $0 (2024) |
| ABBVIE INC. | $156.03 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $508.84 | 22 | Boehringer Ingelheim Pharmaceuticals, Inc. ($167.57) |
| 2023 | $516.30 | 25 | Boehringer Ingelheim Pharmaceuticals, Inc. ($258.27) |
| 2022 | $870.35 | 44 | Horizon Therapeutics plc ($289.03) |
| 2021 | $777.60 | 42 | Horizon Therapeutics plc ($167.10) |
| 2020 | $488.51 | 29 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($146.38) |
| 2019 | $225.21 | 12 | Boehringer Ingelheim Pharmaceuticals, Inc. ($73.27) |
| 2018 | $350.47 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($105.15) |
| 2017 | $1,069 | 59 | Merck Sharp & Dohme Corporation ($271.58) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Diabetes Care | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: DIABETES | ||||||
| 07/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Central Nervous System | ||||||
| 04/25/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: DIABETES MEDICINE | ||||||
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: DIABETES | ||||||
| 03/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: DIABETES | ||||||
| 01/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: DIABETES | ||||||
| 12/20/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: DIABETES | ||||||
| 12/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 207 | 511 | $92,420 | $30,353 |
| 2022 | 6 | 260 | 635 | $103,235 | $37,195 |
| 2021 | 5 | 258 | 672 | $106,120 | $39,374 |
| 2020 | 4 | 236 | 641 | $103,185 | $29,102 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 379 | $75,800 | $21,531 | 28.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $9,400 | $6,622 | 70.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 46 | $5,520 | $1,981 | 35.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 23 | $1,380 | $206.54 | 15.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 16 | $320.00 | $12.01 | 3.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 109 | 409 | $81,800 | $25,971 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $7,000 | $5,179 | 74.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 42 | 85 | $6,375 | $3,651 | 57.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 45 | $5,400 | $2,051 | 38.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 36 | $2,160 | $323.22 | 15.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 18 | 25 | $500.00 | $19.74 | 3.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 436 | $87,150 | $29,261 | 33.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 36 | 36 | $7,200 | $5,441 | 75.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 48 | 102 | $7,650 | $3,987 | 52.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 31 | 54 | $3,240 | $625.52 | 19.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 27 | 44 | $880.00 | $60.30 | 6.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 116 | 424 | $84,800 | $21,910 | 25.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 64 | 137 | $10,225 | $5,226 | 51.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 40 | 56 | $6,720 | $1,696 | 25.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 24 | $1,440 | $269.86 | 18.7% |
About Dr. Muntaz Majeed, M.D
Dr. Muntaz Majeed, M.D is a Internal Medicine healthcare provider based in South Richmond Hill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730258682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muntaz Majeed, M.D has received a total of $4,806 in payments from pharmaceutical and medical device companies, with $508.84 received in 2024. These payments were reported across 253 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($4,806).
As a Medicare-enrolled provider, Majeed has provided services to 961 Medicare beneficiaries, totaling 2,459 services with total Medicare billing of $136,023. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location South Richmond Hill, NY
- Active Since 11/07/2006
- Last Updated 09/12/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1730258682
Products in Payments
- TRADJENTA (Drug) $467.45
- JARDIANCE (Drug) $396.22
- PENNSAID (Drug) $341.11
- JANUVIA (Drug) $307.34
- XARELTO (Drug) $274.04
- RAYOS (Drug) $239.83
- BELSOMRA (Drug) $210.62
- FARXIGA (Drug) $208.33
- XIFAXAN (Drug) $178.89
- TRULICITY (Drug) $168.86
- Vascepa (Drug) $168.21
- UBRELVY (Drug) $156.32
- BREZTRI (Drug) $139.67
- AFREZZA (Drug) $138.57
- ENTRESTO (Drug) $134.18
- ACTHAR (Biological) $123.25
- INVOKANA (Drug) $104.56
- FREESTYLE LIBRE 2 (Device) $70.85
- Ozempic (Drug) $70.51
- SYNJARDY (Drug) $69.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in South Richmond Hill
Dr. Kathleen Kohut, D.o, D.O
Internal Medicine — Payments: $6,644
Dr. Amarjit Singh, M.d, M.D
Internal Medicine — Payments: $4,296
Faisal Waseem, M.d, M.D
Internal Medicine — Payments: $3,478
Dr. Manjit Cheema, Md, MD
Internal Medicine — Payments: $1,907
Harmandeep Singh, D.o, D.O
Internal Medicine — Payments: $1,222
Howard Chung, Md, MD
Internal Medicine — Payments: $247.06